Abbott Laboratories
NYSE:ABT
Gross Margin
Abbott Laboratories
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Gross Margin Comparison
Abbott Laboratories Competitors
Country | US |
Market Cap | 182.1B USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 131B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 125.8B USD |
Gross Margin |
64%
|
Country | IE |
Market Cap | 104.4B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 99.3B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 66.7B USD |
Gross Margin |
41%
|
Country | DE |
Market Cap | 57.3B EUR |
Gross Margin |
36%
|
Country | US |
Market Cap | 52.1B USD |
Gross Margin |
77%
|
Country | US |
Market Cap | 51.9B USD |
Gross Margin |
64%
|
Country | CN |
Market Cap | 329.2B CNY |
Gross Margin |
65%
|
Country | US |
Market Cap | 39.9B USD |
Gross Margin |
60%
|
Profitability Report
View the profitability report to see the full profitability analysis for Abbott Laboratories.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Abbott Laboratories's most recent financial statements, the company has Gross Margin of 55.3%.